MAZZONE, ELIO
 Distribuzione geografica
Continente #
EU - Europa 387
NA - Nord America 312
AS - Asia 112
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 816
Nazione #
US - Stati Uniti d'America 312
SE - Svezia 184
IT - Italia 84
CN - Cina 54
RU - Federazione Russa 44
SG - Singapore 37
FI - Finlandia 21
DE - Germania 16
ES - Italia 8
GB - Regno Unito 8
IN - India 7
NL - Olanda 6
PT - Portogallo 5
IE - Irlanda 3
IR - Iran 3
BE - Belgio 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IL - Israele 2
JP - Giappone 2
KR - Corea 2
TW - Taiwan 2
AU - Australia 1
GR - Grecia 1
HK - Hong Kong 1
MK - Macedonia 1
PL - Polonia 1
PY - Paraguay 1
SA - Arabia Saudita 1
TR - Turchia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 816
Città #
New York 68
Lawrence 42
Princeton 42
Shanghai 37
Ashburn 33
Milan 33
Singapore 24
Boardman 22
Helsinki 19
Moscow 19
Pune 6
Rome 5
Amsterdam 4
Borås 4
Lisbon 4
Palermo 4
Salamanca 4
Aci Sant'antonio 3
Bodmin 3
Dublin 3
Los Angeles 3
Paderborn 3
Seattle 3
Aberdeen 2
Ancona 2
Bethesda 2
Brussels 2
Cairo 2
Calceranica al Lago 2
Gangnam-gu 2
Hsinchu 2
Petah Tikva 2
Tokyo 2
Vaprio d'Adda 2
Vazzola 2
Asunción 1
Athens 1
Bari 1
Bologna 1
Braga 1
Buffalo 1
Chicago 1
Council Bluffs 1
Crotone 1
Freiburg im Breisgau 1
Gaithersburg 1
Giussano 1
Gunzenhausen 1
Hanover 1
Henderson 1
Istanbul 1
Jeddah 1
Johannesburg 1
Kunming 1
Lappeenranta 1
London 1
Lucca 1
Macerata 1
Mumbai 1
Naaldwijk 1
Nov Dojran 1
Oegstgeest 1
Ostra 1
Padova 1
Penn Yan 1
Portsmouth 1
Predosa 1
Santa Clara 1
Segrate 1
Sesto San Giovanni 1
Sydney 1
Talavera de la Reina 1
Tower Hamlets 1
Washington 1
Totale 451
Nome #
INTEGRATING PSMA EXPRESSION PATTERNS, MORPHOLOGICAL AND CLINICAL FEATURES TO OPTIMIZE DETECTION OF NODAL METASTASES IN PATIENTS TREATED WITH PSMA RADIO-GUIDED ROBOT-ASSISTED RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION 65
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 34
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 29
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 27
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 26
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 25
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 23
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 23
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 23
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 21
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 21
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 20
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups 19
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 19
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate 19
Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series 19
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 17
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 17
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes 17
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 17
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 17
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 16
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter 16
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality 16
Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population-based analysis 16
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis 16
Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study 15
Conditional survival of patients with stage I–III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality 15
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates 15
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study 15
Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis 15
Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy 15
Contemporary clinicopathological characteristics of pT0 prostate cancer at radical prostatectomy: A population-based study 15
Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients 14
Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma 14
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 13
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 13
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 13
Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient Sample 12
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought 12
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma 11
Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract 11
The effect of race on survival after local therapy in metastatic prostate cancer patients 11
Trends and social barriers for inpatient palliative care in patients with metastatic bladder cancer receiving critical care therapies 11
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 11
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 9
Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma 9
Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma 8
Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies 8
Primary lymphomas of the genitourinary tract: A population-based study 7
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes 7
Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis 7
null 1
Totale 885
Categoria #
all - tutte 10.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 2 0 0 0 0 0 0 0
2020/202128 0 0 0 0 0 28 0 0 0 0 0 0
2021/202243 0 6 2 18 0 3 1 1 0 0 0 12
2022/2023322 109 73 29 13 5 33 7 27 13 0 6 7
2023/2024396 2 18 38 22 28 88 6 38 6 38 45 67
2024/202593 93 0 0 0 0 0 0 0 0 0 0 0
Totale 885